Blagden N, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev. 2007;59(7):617–30. Available from: https://www.sciencedirect.com/science/article/pii/S0169409X07000828.

Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012;2012(100 mL):1–10.

Bavishi DD, Borkhataria CH. Spring and parachute: how cocrystals enhance solubility. Prog Cryst Growth Charact Mater. 2016;62(3):1–8.

Article  CAS  Google Scholar 

Urso R, Blardi P, Giorgi G. A short introduction to pharmacokinetics. Eur Rev Med Pharmacol Sci. 2002;6(2):33–44.

PubMed  CAS  Google Scholar 

Kotak U, Prajapati V, Solanki H, Jani G, Jha P. Co-crystallization technique - its rationale and recent progress. World J Pharm Pharm Sci. 2015;4(04):1484–508.

CAS  Google Scholar 

Vaghela P, Tank HM, Jalpa P. Cocrystals : a novel approach to improve the physicochemical and mechanical properties. Indo Am J Pharm Res. 2014;4(10).

Desiraju G. Crystal engineering: a brief overview. J Chem Sci. 2010;122:667–75.

Article  CAS  Google Scholar 

Elliott WJ, Ram CVS. Calcium channel blockers. J Clin Hypertens (Greenwich). 2011;13(9):687–9.

Article  PubMed  CAS  Google Scholar 

Mahmoud SH, Ji X, Isse FA. Nimodipine pharmacokinetic variability in various patient populations. Drugs R D. 2020;20(4):307–18.

Article  PubMed  PubMed Central  Google Scholar 

Riekes MK, Caon T, da Silva J, Sordi R, Kuminek G, Bernardi LS, et al. Enhanced hypotensive effect of NMD solid dispersions produced by supercritical CO2 drying. Powder Technol. 2015;278:204–10.

Article  CAS  Google Scholar 

Zhao Y, Xin T, Ye T, Yang X, Pan W. Solid dispersion in the development of a NMD delayed-release tablet formulation. Asian J Pharm Sci. 2014;9(1):35–41.

Article  Google Scholar 

Sun Y, Rui Y, Wenliang Z, Tang X. NMD semi-solid capsules containing solid dispersion for improving dissolution. Int J Pharm. 2008;359(1):144–9.

Article  PubMed  CAS  Google Scholar 

Zu Y, Li N, Zhao X, Li Y, Ge Y, Wang W, et al. In vitro dissolution enhancement of micronized l-NMD by antisolvent re-crystallization from its crystal form H. Int J Pharm. 2014;464(1):1–9.

Article  PubMed  CAS  Google Scholar 

Hänggi D, Etminan N, Macdonald RL, Steiger HJ, Mayer SA, Aldrich F, et al. NEWTON: NMD microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage. Neurocrit Care. 2015;23(2):274–84.

Article  PubMed  Google Scholar 

Fu Q, Sun J, Zhang D, Li M, Wang Y, Ling G, et al. NMD nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies. Colloids Surf B Biointerfaces. 2013;109:161–6.

Article  PubMed  CAS  Google Scholar 

Yu J, He HB, Tang X. Formulation and evaluation of NMD-loaded lipid microspheres. J Pharm Pharmacol. 2006;58(11):1429–35.

Article  PubMed  CAS  Google Scholar 

Xiong R, Lu W, Li J, Wang P, Xu R, Chen T. Preparation and characterization of intravenously injectable NMD nanosuspension. Int J Pharm. 2008;350(1):338–43.

Article  PubMed  CAS  Google Scholar 

Fu Q, Kou L, Gong C, Li M, Sun J, Zhang D, et al. Relationship between dissolution and bioavailability for NMD colloidal dispersions: the critical size in improving bioavailability. Int J Pharm. 2012;427(2):358–64.

Article  PubMed  CAS  Google Scholar 

Liu M, Hong C, Yao Y, Shen H, Ji G, Li G, et al. Development of a pharmaceutical cocrystal with solution crystallization technology: preparation, characterization, and evaluation of myricetin-proline cocrystals. Eur J Pharm Biopharm. 2016;107:151–9.

Article  PubMed  CAS  Google Scholar 

Alatas F, Ratih H, Soewandhi SN. Enhancement of solubility and dissolution rate of telmisartan by telmisartan-oxalic acid co-crystal formation. Int J Pharm Pharm Sci. 2015;7(3):423–6.

CAS  Google Scholar 

Hiendrawan S, Hartanti AW, Veriansyah B, Widjojokusumo E, Tjandrawinata RR. Solubility enhancement of ketoconazole via salt and cocrystal formation. Int J Pharm Pharm Sci. 2015;7(7):160–4.

CAS  Google Scholar 

Shewale S, Shete AS, Doijad RC, Kadam SS, Patil VA, Yadav AV. Formulation and solid state characterization of nicotinamide-based co-crystals of fenofibrate. Indian J Pharm Sci. 2015;77(3):328–34.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sarkar A, Rohani S. Cocrystals of acyclovir with promising physicochemical properties. J Pharm Sci. 2015;104(1):98–105.

Article  PubMed  CAS  Google Scholar 

Shah K, Borhade SD, Londhe V. Utilization of co-crystallization for solubility enhancement of a poorly soluble antiretroviral drug - RITONAVIR. Int j Pharm Pharm Sci. 2014;(2):556–8.

Sanphui P, Devi VK, Clara D, Malviya N, Ganguly S, Desiraju GR. Cocrystals of hydrochlorothiazide: solubility and diffusion/permeability enhancements through drug–coformer interactions. Mol Pharm. 2015;12(5):1615–22.

Article  PubMed  CAS  Google Scholar 

Lee G, Goosens KA. Sampling blood from the lateral tail vein of the rat. J Vis Exp. 2015;99: e52766.

Google Scholar 

Brahmankar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics: a treatise. Vallabh Prakashan. 2005. Available from: https://books.google.co.in/books?id=PVCEMwEACAAJ.

Zhang Q, Jiang X, Wu C. Distribution of NMD in brain following intranasal administration in rats. Acta Pharmacol Sin. 2004;25(4):522–7.

PubMed  CAS  Google Scholar 

Paduszyński K. Extensive evaluation of the conductor-like screening model for real solvents method in predicting liquid-liquid equilibria in ternary systems of ionic liquids with molecular compounds. J Phys Chem B. 2018;122(14):4016–28.

Article  PubMed  Google Scholar 

Sathisaran I, Dalvi SV. Crystal engineering of curcumin with salicylic acid and hydroxyquinol as coformers. Cryst Growth Des. 2017;17(7):3974–88.

Article  CAS  Google Scholar 

Panzade P, Shendarkar G, Shaikh S, Rathi PB. Pharmaceutical cocrystal of piroxicam: design, formulation and evaluation. Adv Pharm Bull. 2017;7(3):399–408.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lu E, Rodríguez-Hornedo N, Suryanarayanan R. A rapid thermal method for cocrystal screening. CrystEngComm. 2008;10(6):665–8.

Article  CAS  Google Scholar 

Beck R, Nyster TO, Enstad GG, Malthe-Sørenssen D, Andreassen JP. Influence of crystal properties on powder flow behavior of an aromatic amine and l-glutamic acid. Part Sci Technol. 2010;28(2):146–60.

Article  CAS  Google Scholar 

Rahman Z, Agarabi C, Zidan AS, Khan SR, Khan MA. Physico-mechanical and stability evaluation of carbamazepine cocrystal with nicotinamide. AAPS PharmSciTech. 2011;12(2):693–704.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Emami S, Siahi-Shadbad M, Adibkia K, Barzegar-Jalali M. Recent advances in improving oral drug bioavailability by cocrystals. BioImpacts. 2018;8(4):305–20.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Towart R, Wehinger E, Meyer H, Kazda S. The effects of NMD, its optical isomers and metabolites on isolated vascular smooth muscle. Arzneimittelforschung. 1982;32(4):338–46.

PubMed  CAS  Google Scholar 

Wessell A, Kole MJ, Badjatia N, Parikh G, Albrecht JS, Schreibman DL, et al. High compliance with scheduled NMD is associated with better outcome in aneurysmal subarachnoid hemorrhage patients cotreated with heparin infusion. Front Neurol. 2017;8:268.

Article  PubMed  PubMed Central  Google Scholar 

Herbette LG, Mason PE, Sweeney KR, Trumbore MW, Mason RP. Favorable amphiphilicity of NMD facilitates its interactions with brain membranes. Neuropharmacology. 1994;33(2):241–9.

Article  PubMed  CAS  Google Scholar